113. Muscular dystrophy Clinical trials / Disease details

Clinical trials : 622 / Drugs : 485 - (DrugBank : 99) / Drug target genes : 59 - Drug target pathways : 168

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01995032 (ClinicalTrials.gov)	October 2013	20/11/2013	L-citrulline and Metformin in Duchenne's Muscular Dystrophy	A Double Blind Randomised Placebo Controlled Efficacy and Safety Study of L-citrulline and Metformin in Ambulant Children Aged Between 7 and 10 Years With Duchenne's Muscular Dystrophy	Duchenne's Muscular Dystrophy (DMD)	Drug: 750 mg metformin and 7.5 g L-citrulline daily p.o.;Drug: Placebo	University Hospital, Basel, Switzerland	NULL	Completed	78 Months	10 Years	All	47	Phase 3	Switzerland
2	NCT02018731 (ClinicalTrials.gov)	June 2013	17/12/2013	L-citrulline and Metformin in Becker's Muscular Dystrophy	Pilot Study to Assess the Efficacy of L-Citrulline and Metformin in Adults With Becker's Muscular Dystrophy	Becker's Muscular Dystrophy (BMD)	Drug: Metformin and Metformin & L-Citrulline;Drug: L-Citrulline and Metformin & L-Citrulline	University Hospital, Basel, Switzerland	NULL	Completed	18 Years	N/A	Both	20	Phase 2	Switzerland